Cargando…
Impact of the Controlled Release of a Connexin 43 Peptide on Corneal Wound Closure in an STZ Model of Type I Diabetes
The alpha-carboxy terminus 1 (αCT1) peptide is a synthetically produced mimetic modified from the DDLEI C-terminus sequence of connexin 43 (Cx43). Previous research using various wound healing models have found promising therapeutic effects when applying the drug, resulting in increased wound healin...
Autores principales: | Moore, Keith, Ghatnekar, Gautam, Gourdie, Robert G., Potts, Jay D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900565/ https://www.ncbi.nlm.nih.gov/pubmed/24466155 http://dx.doi.org/10.1371/journal.pone.0086570 |
Ejemplares similares
-
Connexin 43-Based Therapeutics for Dermal Wound Healing
por: Montgomery, Jade, et al.
Publicado: (2018) -
The Effect of a Connexin43-Based Peptide on the Healing of Chronic Venous Leg Ulcers: A Multicenter, Randomized Trial
por: Ghatnekar, Gautam S, et al.
Publicado: (2015) -
Peptidic Connexin43 Therapeutics in Cardiac Reparative Medicine
por: Marsh, Spencer R., et al.
Publicado: (2021) -
The Connexin Mimetic Peptide Gap27 and Cx43-Knockdown Reveal Differential Roles for Connexin43 in Wound Closure Events in Skin Model Systems
por: Faniku, Chrysovalantou, et al.
Publicado: (2018) -
Connexin 43 confers chemoresistance through activating PI3K
por: Pridham, Kevin J., et al.
Publicado: (2022)